Health-care names, such as UnitedHealth Group and Johnson & Johnson , also outperformed.
About 73% of analysts covering the health-care stock consider it a buying opportunity, and analysts predict it could rise 17%.
UnitedHealth shares are down more than 3% in 2023.
Johnson & Johnson shares also outperformed this week, up 6.7%.
This week, Johnson & Johnson said it would pay $8.9 billion over the next 25 years to settle allegations that talc in its baby powder and other products caused cancer.
Organizations:
& $